RG
Rathbones Group’s Novo Nordisk NVO Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $2.9M | Buy |
42,048
+42
| +0.1% | +$2.9K | 0.01% | 258 |
|
|
2025
Q1 | $2.92M | Buy |
42,006
+29,993
| +250% | +$2.08M | 0.01% | 245 |
|
|
2024
Q4 | $1.03M | Sell |
12,013
-562
| -4% | -$48.3K | 0.01% | 333 |
|
|
2024
Q3 | $1.5M | Buy |
12,575
+1,805
| +17% | +$215K | 0.01% | 296 |
|
|
2024
Q2 | $1.54M | Sell |
10,770
-6,015
| -36% | -$859K | 0.01% | 284 |
|
|
2024
Q1 | $2.16M | Buy |
16,785
+265
| +2% | +$34K | 0.01% | 261 |
|
|
2023
Q4 | $1.71M | Sell |
16,520
-28
| -0.2% | -$2.9K | 0.01% | 269 |
|
|
2023
Q3 | $1.5M | Buy |
+16,548
| New | +$1.5M | 0.01% | 277 |
|
|
2022
Q4 | – | Sell |
-2,500
| Closed | -$249K | – | 431 |
|
|
2022
Q3 | $249K | Hold |
2,500
| – | – | ﹤0.01% | 352 |
|
|
2022
Q2 | $279K | Hold |
2,500
| – | – | ﹤0.01% | 356 |
|
|
2022
Q1 | $278K | Hold |
2,500
| – | – | ﹤0.01% | 367 |
|
|
2021
Q4 | $280K | Hold |
2,500
| – | – | ﹤0.01% | 371 |
|
|
2021
Q3 | $240K | Hold |
2,500
| – | – | ﹤0.01% | 377 |
|
|
2021
Q2 | $209K | Buy |
+2,500
| New | +$209K | ﹤0.01% | 395 |
|